These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33313060)

  • 1. The Protective Role of Klotho in CKD-Associated Cardiovascular Disease.
    Bi X; Yang K; Zhang B; Zhao J
    Kidney Dis (Basel); 2020 Nov; 6(6):395-406. PubMed ID: 33313060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease.
    Lu X; Hu MC
    Kidney Dis (Basel); 2017 Jul; 3(1):15-23. PubMed ID: 28785560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential application of klotho in human chronic kidney disease.
    Neyra JA; Hu MC
    Bone; 2017 Jul; 100():41-49. PubMed ID: 28115282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of klotho in chronic kidney disease.
    Zou D; Wu W; He Y; Ma S; Gao J
    BMC Nephrol; 2018 Oct; 19(1):285. PubMed ID: 30348110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.
    Hu MC; Shi M; Cho HJ; Adams-Huet B; Paek J; Hill K; Shelton J; Amaral AP; Faul C; Taniguchi M; Wolf M; Brand M; Takahashi M; Kuro-O M; Hill JA; Moe OW
    J Am Soc Nephrol; 2015 Jun; 26(6):1290-302. PubMed ID: 25326585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. αKlotho and Chronic Kidney Disease.
    Neyra JA; Hu MC
    Vitam Horm; 2016; 101():257-310. PubMed ID: 27125746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
    Hu MC; Shi M; Gillings N; Flores B; Takahashi M; Kuro-O M; Moe OW
    Kidney Int; 2017 May; 91(5):1104-1114. PubMed ID: 28131398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF23 and Klotho in chronic kidney disease.
    Olauson H; Larsson TE
    Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):397-404. PubMed ID: 23666415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The axis of local cardiac endogenous Klotho-TGF-β1-Wnt signaling mediates cardiac fibrosis in human.
    Liu Q; Zhu LJ; Waaga-Gasser AM; Ding Y; Cao M; Jadhav SJ; Kirollos S; Shekar PS; Padera RF; Chang YC; Xu X; Zeisberg EM; Charytan DM; Hsiao LL
    J Mol Cell Cardiol; 2019 Nov; 136():113-124. PubMed ID: 31520610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease.
    Kitagawa M; Sugiyama H; Morinaga H; Inoue T; Takiue K; Ogawa A; Yamanari T; Kikumoto Y; Uchida HA; Kitamura S; Maeshima Y; Nakamura K; Ito H; Makino H
    PLoS One; 2013; 8(2):e56695. PubMed ID: 23431388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Klotho, Cardiovascular Events, and Mortality in Nondiabetic Chronic Kidney Disease.
    Yang K; Yang J; Bi X; Yu Z; Xiao T; Huang Y; Liu Y; Xiong J; Zhao J
    Cardiorenal Med; 2020; 10(3):175-187. PubMed ID: 32294646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
    Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
    Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
    Milovanova LY; Milovanov YS; Kudryavtseva DV; Markina MM; Milovanova SY; Kozlovskaya LV; Lebedeva MV; Beketov VD; Moiseev SV; Mukhin NA; Fomin VV; Svistunov AA
    Ter Arkh; 2015; 87(6):10-16. PubMed ID: 26281189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of Soluble α-Klotho as an Independent Cause of Uremic Cardiomyopathy.
    Xie J; Wu YL; Huang CL
    Vitam Horm; 2016; 101():311-30. PubMed ID: 27125747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging role of Klotho in clinical nephrology.
    Hu MC; Kuro-o M; Moe OW
    Nephrol Dial Transplant; 2012 Jul; 27(7):2650-7. PubMed ID: 22802580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between soluble klotho and cardiovascular parameters in chronic kidney disease: results from the KNOW-CKD study.
    Kim HJ; Kang E; Oh YK; Kim YH; Han SH; Yoo TH; Chae DW; Lee J; Ahn C; Oh KH
    BMC Nephrol; 2018 Mar; 19(1):51. PubMed ID: 29506503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of kidney protective factors by inflammation: role of transcription factors and epigenetic mechanisms.
    Ruiz-Andres O; Sanchez-Niño MD; Moreno JA; Ruiz-Ortega M; Ramos AM; Sanz AB; Ortiz A
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1329-F1340. PubMed ID: 27760772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Potential application of fibroblast growth factor 23-klotho axis in chronic kidney disease].
    Lacroix JS; Urena-Torres P
    Nephrol Ther; 2020 Mar; 16(2):83-92. PubMed ID: 31843356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Klotho restoration via acetylation of Peroxisome Proliferation-Activated Receptor γ reduces the progression of chronic kidney disease.
    Lin W; Zhang Q; Liu L; Yin S; Liu Z; Cao W
    Kidney Int; 2017 Sep; 92(3):669-679. PubMed ID: 28416226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between klotho and kidney and cardiovascular outcomes: a comprehensive systematic review and meta-analysis.
    Kanbay M; Brinza C; Ozbek L; Guldan M; Sisman U; Copur S; Covic A; Scripcariu DV; Burlacu A; Covic A
    Clin Kidney J; 2024 Sep; 17(9):sfae255. PubMed ID: 39281418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.